Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c
Tweet Send to a FriendGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
Revenue Growth %: -1.0%
Financial Fact:
Research and development expenses: 493K
Today's EPS Names:
CEDU, CHC, CIDM, More
Revenue Growth %: -1.0%
Financial Fact:
Research and development expenses: 493K
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade OMPI Now!
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $30.64 million.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
